Intellia to cut 27% of workforce, discontinue NTLA-3001
[ad_1]
Intellia to cut 27% of workforce, discontinue NTLA-3001
[ad_2]
Similar Posts
Compass Therapeutics announces advancement of a new drug candidate
Byadmin
[ad_1] Compass Therapeutics announces advancement of a new drug candidate [ad_2]
Context Therapeutics names Andy Pasternak as chair
Byadmin
[ad_1] Context Therapeutics names Andy Pasternak as chair [ad_2]
The Arena Group announces NYSE acceptance of plan to regain compliance
Byadmin
[ad_1] The Arena Group announces NYSE acceptance of plan to regain compliance [ad_2]
Cintas declares $0.39 dividend
Byadmin
[ad_1] Cintas declares $0.39 dividend [ad_2]
Experian goes ex dividend tomorrow
Byadmin
[ad_1] Experian goes ex dividend tomorrow [ad_2]
Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B
Byadmin
[ad_1] Gilead in pact for anti-inflammatory drugs in a deal worth up to $1.7B [ad_2]